Travere Therapeutics
TVTX
TVTX
168 hedge funds and large institutions have $2.03B invested in Travere Therapeutics in 2021 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 50 increasing their positions, 50 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
7.37% more ownership
Funds ownership: 100.25% → 107.62% (+7.4%)
0% more call options, than puts
Call options by funds: $5.27M | Put options by funds: $5.26M
0% more repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 50
Holders
168
Holding in Top 10
8
Calls
$5.27M
Puts
$5.26M
Top Buyers
| 1 | +$46.6M | |
| 2 | +$19.5M | |
| 3 | +$18.7M | |
| 4 |
Invesco
Atlanta,
Georgia
|
+$14.7M |
| 5 |
VA
VR Adviser
New York
|
+$8.15M |
Top Sellers
| 1 | -$20.8M | |
| 2 | -$16.9M | |
| 3 | -$13.8M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$12.3M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$8.49M |